ES2075709T3 - Derivados amidicos del antibiotico a 40926. - Google Patents

Derivados amidicos del antibiotico a 40926.

Info

Publication number
ES2075709T3
ES2075709T3 ES92915890T ES92915890T ES2075709T3 ES 2075709 T3 ES2075709 T3 ES 2075709T3 ES 92915890 T ES92915890 T ES 92915890T ES 92915890 T ES92915890 T ES 92915890T ES 2075709 T3 ES2075709 T3 ES 2075709T3
Authority
ES
Spain
Prior art keywords
antibiotic
amidic derivatives
derivatives
amidic
dialquilaminocaroxybar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92915890T
Other languages
English (en)
Inventor
Adriano Malabarba
Romeo Ciabatti
Gianbattista Panzone
Alessandra Maria Marazzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26128958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2075709(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Application granted granted Critical
Publication of ES2075709T3 publication Critical patent/ES2075709T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION SE DIRIGE A NUEVOS DERIVADOS DEL ANTIBIOTICO A 40926 QUE SE CARACTERIZAN POR TENER UN SUSTITUYENTE DE CARBOXIDO, ALCOXICARBONILO C1-C4, AMINOCARBONILO, ALQUILAMINOCARBONIL C1-C4, DIALQUILAMINOCARBONIL C1-C4 O HIDROXIMETILO SOBRE LA MOLECULA DE NACILAMINOGLUCURONIL Y UN SUSTITUYENTE DE HIDROXIDO O DE POLIAMINO EN LA POSICION 63 DE LA MOLECULA. LOS COMPUESTOS DE LA INVENCION MUESTRAN UNA ALTA ACTIVIDAD IN VITRO CONTRA LOS "ENTEROCOCCI" Y LOS "STAPHILOCOCCI" RESISTENTES A LOS GLICOPEPTIDOS.
ES92915890T 1991-07-29 1992-07-14 Derivados amidicos del antibiotico a 40926. Expired - Lifetime ES2075709T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91112685 1991-07-29
EP92109906 1992-06-12

Publications (1)

Publication Number Publication Date
ES2075709T3 true ES2075709T3 (es) 1995-10-01

Family

ID=26128958

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92915890T Expired - Lifetime ES2075709T3 (es) 1991-07-29 1992-07-14 Derivados amidicos del antibiotico a 40926.

Country Status (24)

Country Link
EP (2) EP0525499A1 (es)
JP (1) JP3418762B2 (es)
KR (1) KR100242682B1 (es)
AT (1) ATE125551T1 (es)
AU (1) AU666862B2 (es)
BG (1) BG61124B2 (es)
CA (1) CA2109601C (es)
CZ (1) CZ285703B6 (es)
DE (1) DE69203724T2 (es)
DK (1) DK0596929T3 (es)
ES (1) ES2075709T3 (es)
FI (1) FI112662B (es)
GR (1) GR3017897T3 (es)
HU (2) HU223946B1 (es)
IE (1) IE68420B1 (es)
IL (1) IL102623A (es)
MX (1) MX9204394A (es)
NO (1) NO314150B1 (es)
NZ (1) NZ243735A (es)
PL (1) PL171813B1 (es)
RU (1) RU2125058C1 (es)
TW (1) TW218021B (es)
UA (1) UA41283C2 (es)
WO (1) WO1993003060A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
NZ270387A (en) * 1994-01-28 1996-11-26 Lilly Co Eli Glycopeptide antibiotic, its production and compositions thereof
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
AU701463B2 (en) * 1995-07-05 1999-01-28 Sanofi Aventis S.P.A. Purification of dalbaheptide antibiotics by isoelectric focusing
DK0912604T3 (da) * 1996-04-23 2002-03-25 Biosearch Italia Spa Forbedret kemisk fremgangsmåde til fremstilling af amidderivater af A 40926 antibiotikum
US6004959A (en) * 1996-05-30 1999-12-21 Hoechst Marion Roussel, Inc. Alkyloxyamino substituted fluorenones and their use as protein kinase-C inhibitors
SG87877A1 (en) * 1998-12-23 2002-04-16 Advanced Medicine Inc Glycopeptide derivatives and pharmaceutical compositions containing the same
US6392012B1 (en) 1998-12-23 2002-05-21 Advanced Medicine, Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
TWI275594B (en) 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
TWI312785B (en) * 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
KR100478533B1 (ko) * 2002-07-30 2005-03-28 한국수력원자력 주식회사 레이저를 이용한 탈륨 동위원소 분리방법
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
EP1565201B1 (en) 2002-11-18 2018-10-31 Vicuron Pharmaceuticals, Inc. Methods of administering dalbavancin for treatment of bacterial infections
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
WO2004110473A1 (en) 2003-05-27 2004-12-23 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
EP1654036B1 (en) 2003-07-22 2007-12-26 Theravance, Inc. Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
WO2006057303A1 (ja) 2004-11-29 2006-06-01 National University Corporation Nagoya University グリコペプチド抗生物質モノマー誘導体
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
AU2008342149A1 (en) 2007-12-26 2009-07-02 Shionogi & Co., Ltd. Glycosylated glycopeptide antibiotic derivative
US20240083950A1 (en) * 2021-01-11 2024-03-14 Xellia Pharmaceuticals Aps Synthesis process

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608809D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Antibiotic
GB8726859D0 (en) * 1987-11-17 1987-12-23 Lepetit Spa 22-dechlorotei-coplanins
DE68925806T2 (de) * 1988-12-27 1996-09-26 Lepetit Spa C63-Amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplaninen
GB2231846B (en) * 1989-05-25 1993-02-24 Hadlum Brothers Ltd A hand held carrier
ATE134379T1 (de) * 1990-12-05 1996-03-15 Lepetit Spa 38-decarboxy-38-hydroxymethylderivate von teicoplaninantibiotika, und verfahren zu deren herstellung
JP3314930B2 (ja) * 1991-03-27 2002-08-19 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ 抗生物質ａ４０９２６エステル誘導体

Also Published As

Publication number Publication date
DE69203724T2 (de) 1996-01-18
CZ285703B6 (cs) 1999-10-13
HU211347A9 (en) 1995-11-28
IE922451A1 (en) 1993-02-10
AU666862B2 (en) 1996-02-29
HUT66080A (en) 1994-09-28
UA41283C2 (uk) 2001-09-17
CA2109601A1 (en) 1993-02-18
MX9204394A (es) 1993-01-29
NO934722D0 (no) 1993-12-20
DK0596929T3 (da) 1995-09-11
HU9400256D0 (en) 1994-05-30
AU2326292A (en) 1993-03-02
JP3418762B2 (ja) 2003-06-23
NZ243735A (en) 1995-01-27
KR100242682B1 (ko) 2000-02-01
RU2125058C1 (ru) 1999-01-20
FI940394L (fi) 1994-01-26
IL102623A0 (en) 1993-01-14
PL171813B1 (pl) 1997-06-30
NO314150B1 (no) 2003-02-03
DE69203724D1 (de) 1995-08-31
JPH06509347A (ja) 1994-10-20
WO1993003060A1 (en) 1993-02-18
EP0596929A1 (en) 1994-05-18
CZ19294A3 (en) 1994-11-16
EP0596929B1 (en) 1995-07-26
TW218021B (es) 1993-12-21
ATE125551T1 (de) 1995-08-15
FI940394A0 (fi) 1994-01-26
GR3017897T3 (en) 1996-01-31
EP0525499A1 (en) 1993-02-03
HU223946B1 (hu) 2005-03-29
IL102623A (en) 1996-10-16
BG61124B2 (bg) 1996-11-29
FI112662B (fi) 2003-12-31
CA2109601C (en) 2002-07-02
NO934722L (no) 1994-02-14
IE68420B1 (en) 1996-06-12

Similar Documents

Publication Publication Date Title
ES2055197T3 (es) Una composicion que contiene d-cicloserina y d-alanina para el aumento de la memoria y el aprendizaje o el tratamiento de un trastorno cognitivo o psicotico.
ES2106112T3 (es) Derivados de indano-2-mercaptoacetilamida con una actividad inhibidora de encefalinasa y de ace.
PT1109812E (pt) Pirrolobenzodiazepinas
AR033796A1 (es) Composicion farmaceutica
ES2052717T3 (es) Uso de derivados de indolona para la preparacion de medicamentos para el tratamiento de la enfermedad de parkinson.
AR038434A2 (es) Compuesto 14,15-dihidro-16-oxoparahercuamida y compuestos 2-desoxo de parahercuamida y marcfortina
ES2170102T3 (es) Aminociclohexilesteres y utilizacion de los mismos.
ES2109949T3 (es) Alteracion enzimatica del crecimiento del pelo.
IL145602A0 (en) Pharmaceutical compounds
ES2106463T3 (es) 3-desoxi-oligosacaridos, procedimientos para su obtencion y composiciones farmaceuticas que los contienen.
DE69034070D1 (de) Racemisches Huperzin A
IT1269176B (it) Eterobicicli ad attivita' fungicida
ES2062215T3 (es) Derivados aminoalcoxibencenicos sustituidos.
LU92263I2 (fr) Imépitoïne et ses dérivés pharmaceutiquement acceptables (PEXION)
ES2045052T3 (es) Antagonistas de leucotrienos ltd4 y ltb4.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
ES2055867T3 (es) Derivados de dibenzotiazepina utiles como agentes antiespasmodicos.
CO5150179A1 (es) Derivados de n-etilpirimidin o (piridin)-2-(1,2-benzoisoxa- zol-3-il)-octahidro-2h-pirido[1,2-a]pirazina y sus composiciones farmaceuticas
ES2110185T3 (es) Complejos de beta-lactama biciclica/parabeno.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
IT1251838B (it) Uso della nimesulide nel trattamento della cataratta
ES2182090T3 (es) Nuevos derivados de pirrol.
UY26144A1 (es) Nuevas formas cristalinas de un antibiótico macrolido.
MY111439A (en) Thymosin alpha 1 derivatives

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 596929

Country of ref document: ES